Selexys develops novel therapeutics for the treatment of inflammatory and thrombotic diseases... Read more
Selexys develops novel therapeutics for the treatment of inflammatory and thrombotic diseases... Read more
News
Dec 12, 2017
BioPortfolio
Selexys Pharmaceuticals: Selexys Pharmaceuticals Corp Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 28112017 Prices from USD $250
Jan 05, 2017
BioPortfolio
Selexys Pharmaceuticals: Selexys Pharmaceuticals Corp Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250
Dec 12, 2016
BioPortfolio
Selexys Pharmaceuticals: Selexys Pharmaceuticals Corporation Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350
Nov 28, 2016
NewsOk
Selexys Pharmaceuticals: Selexys a local success story for entrepreneurship
Nov 21, 2016
The Financial Times
Selexys Pharmaceuticals: Novartis acquires Selexys in deal worth up to $665m
Sep 22, 2015
PR-INSIDE.COM
Press Release: Selexys : Selexys Pharmaceuticals Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
May 12, 2015
PR-INSIDE.COM
Press Release: Selexys : Selexys Pharmaceuticals Corporation - Pharmaceuticals & Healthcare - Deals and Alliances Profile - New Study Released
May 07, 2014
PHARMACEUTICAL BUSINESS REVIEW
Selexys: Selexys to offer process development, cGMP manufacturing services for Cytovance's SELK2
May 07, 2014
CONTRACT PHARMA
Selexys: Cytovance, Selexys Enter cGMP Mfg. Alliance
May 06, 2014
MARKETWIRED
Press Release: Selexys : Cytovance Biologics, Inc. and Selexys Pharmaceuticals, Corp. Announce Development and cGMP Manufacturing Agreement for SELK2 Drug Product
Selexys Pharmaceuticals Competitors
1
2
3
4
5
6
7
8
9
10